Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
Authors:
Open Access
- 1 May 2021
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 10, 100133
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization (2018ZX09734004)
- National Major Science and Technology Projects of China (2018ZX09734004)
This publication has 14 references indexed in Scilit:
- Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in ChinaOpen Forum Infectious Diseases, 2019
- Immunogenicity and Safety of a Sabin Strain–Based Inactivated Polio Vaccine: A Phase 3 Clinical TrialThe Journal of Infectious Diseases, 2019
- Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication EndgameClinical Infectious Diseases, 2018
- Standardized Methods for Detection of Poliovirus Antibodies2016
- Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trialThe Lancet, 2015
- Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in ChinaJournal of the Pediatric Infectious Diseases Society, 2015
- The New Polio Eradication End Game: Rationale and Supporting EvidenceThe Journal of Infectious Diseases, 2014
- Innovative IPV From Attenuated Sabin Poliovirus Or Newly Designed Alternative Seed StrainsPharmaceutical Patent Analyst, 2012
- Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus ChallengePLOS Pathogens, 2012
- Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trialThe Lancet Infectious Diseases, 2012